Sign In
Buy RAPT
$58.02
+0 (+0%)
At Close: Jun 01, 2026
Rapt Therapeutics (RAPT) Upgraded to Buy: Here's What You Should Know
01:32pm, Friday, 23'rd Sep 2022
Rapt Therapeutics (RAPT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
How Much Upside is Left in Rapt Therapeutics (RAPT)? Wall Street Analysts Think 74%
01:55pm, Thursday, 01'st Sep 2022 Zacks Investment Research
The average of price targets set by Wall Street analysts indicates a potential upside of 73.7% in Rapt Therapeutics (RAPT). While the effectiveness of this highly sought-after metric is questionable,
How Much Upside is Left in Rapt Therapeutics (RAPT)? Wall Street Analysts Think 74%
11:34am, Thursday, 01'st Sep 2022
The average of price targets set by Wall Street analysts indicates a potential upside of 73.7% in Rapt Therapeutics (RAPT). While the effectiveness of this highly sought-after metric is questionable,
RAPT Therapeutics to Participate in Several Upcoming Investor Conferences in September
08:00am, Wednesday, 31'st Aug 2022
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing a
Can Rapt Therapeutics (RAPT) Climb 59% to Reach the Level Wall Street Analysts Expect?
01:55pm, Tuesday, 16'th Aug 2022 Zacks Investment Research
The average of price targets set by Wall Street analysts indicates a potential upside of 58.9% in Rapt Therapeutics (RAPT). While the effectiveness of this highly sought-after metric is questionable,
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
07:43am, Monday, 15'th Aug 2022 Benzinga
Gainers
Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.
Twin Vee Powercats Co. (NASDAQ: VEEE) shares cl
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session
04:54pm, Friday, 12'th Aug 2022 Benzinga
Gainers
Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year.
Unity Biotechnology, Inc. (NYSE: UBX) jumped 70% to $1.4492 af
HC Wainwright & Co. Maintains Buy Rating for RAPT Therapeutics: Here's What You Need To Know
04:19pm, Friday, 12'th Aug 2022 Benzinga
HC Wainwright & Co. has decided to maintain its Buy rating of RAPT Therapeutics (NASDAQ:RAPT) and raise its price target from $50.00 to $53.00.
Shares of RAPT Therapeutics are trading up 14.98% over t
LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday
03:59pm, Friday, 12'th Aug 2022 Benzinga
Altimmune, Inc. (NASDAQ: ALT) jumped 28% to $17.64. B. Riley Securities maintained Altimmune with a Buy and raised the price target from $21 to $26.
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) ju
Expert Ratings For RAPT Therapeutics
12:18pm, Friday, 12'th Aug 2022 Benzinga
RAPT Therapeutics (NASDAQ:RAPT) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
2
0
0
0
La
Rapt Therapeutics (RAPT) Reports Q2 Loss, Tops Revenue Estimates
01:15pm, Thursday, 11'th Aug 2022 Zacks Investment Research
Rapt Therapeutics (RAPT) delivered earnings and revenue surprises of 17.33% and 121.50%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Lags Revenue Estimates
12:35pm, Tuesday, 09'th Aug 2022 Zacks Investment Research
Clearside Biomedical, Inc. (CLSD) delivered earnings and revenue surprises of 0% and 48.80%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Gritstone bio Inc. (GRTS) Reports Q2 Loss, Tops Revenue Estimates
10:35pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Gritstone bio Inc. (GRTS) delivered earnings and revenue surprises of 15% and 117.10%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
09:55am, Friday, 29'th Jul 2022 Benzinga
Gainers
Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 20
Regeneron (REGN) Moves 4.4% Higher: Will This Strength Last?
01:25pm, Monday, 20'th Jun 2022 Zacks Investment Research
Regeneron (REGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength
